Drug Type Antibody drug conjugate (ADC) |
Synonyms- |
Target |
Mechanism CD45 modulators(Leukocyte common antigen modulators), c-Kit inhibitors(Stem cell growth factor receptor inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Genetic Diseases, Inborn | Preclinical | DE | 30 Nov 2022 | |
Genetic Diseases, Inborn | Preclinical | US | 30 Nov 2022 | |
Hematologic Neoplasms | Preclinical | US | 30 Nov 2022 | |
Hematologic Neoplasms | Preclinical | DE | 30 Nov 2022 |